IPO Guru
Listed Mainboard

Advance Agrolife IPO Review

Advance Agrolife IPO has been reviewed by 6 analysts, and the overall consensus is Apply — carrying a score of 77. Out of the 6 analysts who have covered this IPO, 3 recommend subscribing while 3 advise caution or avoidance — reflecting a broadly positive view from the analyst community.

The issue is priced in the band of ₹95-100 per share, with a minimum application size of 150 shares (minimum investment of approximately ₹15,000 at the upper band). Subscription ran from 30 Sep 2025 to 03 Oct 2025. The issue size is ₹193 crore, entirely a fresh issue. Scroll down for the full analyst breakdown and analyst-wise verdicts.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Analyst verdict & score

One score out of 100, aggregated from every analyst verdict tracked for this issue. How it's calculated

Sentiment score
77/ 100
Apply 3 of 6 recommend subscribing
How analysts voted
Apply 3
May apply 1
Neutral 2

Higher consensus indicates broader analyst agreement.

Detailed review

What the analyst reports say, grouped by the question you're likely asking.

General review

Advance Agrolife manufactures agrochemicals. Revenue grew steadily from ₹397.97 crore in FY23 to ₹502.88 crore in FY25, with operating margin improving each year from 6.3 to 9.5 percent and EBITDA reaching ₹48.25 crore. Of the five analysts covering it, three said subscribe and two stayed neutral.

Listing gains

Coverage was limited and the tone measured, with three subscribe ratings against two neutral views on a small ₹193 crore issue priced at ₹95 to ₹100. The absence of any strong valuation argument in the notes, in either direction, pointed to a modest listing expectation.

Short-term strategy

The margin trend is the clearest positive, rising from 6.3 percent in FY23 to 8.5 percent in FY24 and 9.5 percent in FY25 on steadily growing revenue. Agrochemical demand depends on the monsoon and crop cycle, so near-term earnings carry the usual seasonal variability.

Long-term strategy

The long-term case rests on consistent revenue growth with expanding margins in a sector supported by structural agricultural demand. With only three positive notes and no detailed valuation case published, the coverage gives a modest rather than emphatic endorsement for a long holding period.

How this is written: an AI-assisted summary of the 6 analyst reports listed below. It reports their views; IPO Guru does not make buy or sell recommendations.

Analyst reviews

Ordered by each analyst's track record over the past year; analysts still building one are listed last.

Latest IPO reviews

How analysts rated the most recent mainboard issues — and, where they have listed, how the call played out.

Frequently asked

Should I apply for Advance Agrolife IPO?

The analyst consensus for Advance Agrolife IPO tracked on this page is Apply, with a score of 77/100. Out of 6 analysts who have reviewed this IPO, 3 recommend subscribing. IPO Guru does not make buy or sell recommendations. Read the individual analyst reports and consult a SEBI-registered advisor before investing.

What does the score of 77 mean for Advance Agrolife IPO?

The score of 77 is an aggregate of all analyst ratings tracked for Advance Agrolife IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Read the individual analyst verdicts above for more context.

What was the actual listing price of Advance Agrolife IPO?

Advance Agrolife IPO listed on October 8, 2025 at ₹114, against the issue price of ₹100 — a gain of +14% (₹14 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of Advance Agrolife IPO?

Advance Agrolife IPO was priced at ₹95-100 per share. The minimum lot size is 150 shares, making the minimum investment approximately ₹15,000 at the upper end of the price band. Subscription ran from 30 Sep 2025 to 03 Oct 2025.

Explore Advance Agrolife IPO further

Analyst views are one input. Read them alongside the demand, the grey market and the filings before you decide.

Advance Agrolife IPO review

A verdict is an opinion, not a guarantee.

IPO Guru collects analyst views, GMP, subscription and allotment for every Mainboard and SME issue. Weigh them together — and against the offer document — before you apply.

Join the WhatsApp channel Full IPO details

Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.

Consensus
Apply
Score
77 / 100
Listed at
₹114
Full IPO details